Natrixam (Indapamide, Amlodipine Besilate)

Natrixam is used to treat hypertension, a condition characterized by elevated arterial blood pressure.

• Essential hypertension: helps achieve target blood pressure levels.
• Primary systolic hypertension: reduces systolic pressure in older patients.
• Hypertension requiring combination therapy: provides dual action when monotherapy is insufficient.

• Indapamide inhibits sodium reabsorption in the distal renal tubule, promoting diuresis and decreasing plasma volume. Amlodipine besilate blocks L‑type calcium channels in vascular smooth muscle, leading to arterial vasodilation. The combined actions lower systemic vascular resistance and cardiac preload, resulting in a sustained reduction of blood pressure.

Natrixam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Peripheral edema: swelling of the ankles or lower legs.
• Dizziness or light‑headedness: especially after standing.
• Flushing: transient warmth and redness of the skin.
• Fatigue: feeling unusually tired.
• Nausea: mild stomach upset.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure.
• Electrolyte imbalance: low potassium or sodium levels.
• Acute kidney injury: sudden decline in renal function.
• Hepatic dysfunction: abnormal liver enzymes.
• Allergic reactions: rash, itching, or swelling of the face.
• Cardiac arrhythmias: irregular heart rhythms.

Before initiating Natrixam, consider patient‑specific factors and monitor appropriately.

• Renal impairment: assess kidney function and adjust therapy if needed.
• Hepatic disease: use with caution in patients with liver dysfunction.
• Electrolyte disturbances: monitor potassium and sodium levels regularly.
• Concomitant antihypertensives: avoid excessive blood pressure lowering.
• Pregnancy and lactation: discuss risks with a healthcare professional.
• Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and light.

Natrixam can interact with several medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase amlodipine exposure.
• Lithium: risk of lithium toxicity due to reduced renal clearance.
• NSAIDs: can blunt diuretic effect and impair renal function.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may enhance hypotensive effect.

• Beta‑blockers: additive blood pressure lowering.
• CYP3A4 inducers (e.g., rifampicin): may reduce amlodipine levels.